Scholar Rock Holding SRRK 深 沪
已收盘 08-21 16:00:00 美东时间
56.50
+1.250
+2.26%
华盛通- 最 高57.10
- 今 开55.38
- 成交量 115.64万股
- 最 低 54.98
- 昨 收 55.25
- 总市值 68.81亿
- 52周最高 58.49
- 市盈率 静 --
- 换手率 0.95%
- 52周最低 27.07
- 委 比 -58.68%
- 总股本 1.22亿
- 历史最高 70.00
- 量 比 1.08
- 振 幅 3.84%
- 历史最低 4.325
- 每 手 1
- 风险率 7.31%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Scholar Rock Removes Catalent Indiana As Commercial Fill-Finish Facility From Its Apitegromab BLA For The Treatment Of Spinal Muscular Atrophy Under Guidance From The FDA; Now On Track To Submit Apitegromab Japanese New Drug Application By End-2026
FDA review of BLA progressing well with Scholar Rock’s alternate fill-finish facility Company is prepared for U.S. apitegromab launch immediately upon FDA approval, which may be granted at any time through September 30, 2026 Prescription Drug User Fee Act (PDUFA) date; robust supply of apitegromab c...
08-21 21:11
美股大行评级 | 潜在涨幅544.53%！Scynexis获古根海姆升目标价至33美元，维持"买入"评级
今日重点评级关注：古根海姆：维持Scynexis"买入"评级，目标价从24美元升至33美元；韦德布什：维持Kura Oncology"跑赢大市"评级，目标价从36美元升至38美元
08-14 11:51
JP Morgan Maintains Overweight on Scholar Rock Holding, Raises Price Target to $63
JP Morgan analyst Tessa Romero maintains Scholar Rock Holding (NASDAQ:SRRK) with a Overweight and raises the price target from $56 to $63.
08-13 23:09
美股大行评级 | Take-Two、Csquare、Standard获多家大行首予买入评级！潜在涨幅215.32%！HC Wainwright.升Innate Pharma(IPHA)目标价至7美元
今日重点评级关注：HC Wainwright & Co.：维持Innate Pharma"买入"评级，目标价从5美元升至7美元；HC Wainwright & Co.：维持Immix Biopharma"买入"评级，目标价从20美元升至25美元
08-11 11:45
美股大行评级 | 花旗下调美光科技目标价从1400美元降至1150美元；爱彼迎、Datadog、Cloudflare、Etsy、Natera、拉夫劳伦获多家大行上调目标价
今日重点评级关注：康托·菲茨杰拉德：维持InflaRx"超配"评级，目标价从4美元升至6美元；RBC Capital：维持Nuvation Bio"跑赢大市"评级，目标价从19美元升至20美元
08-10 19:24
财报速睇 | Scholar Rock Holding 2026财年Q2营收0.00亿美元，同比增长0.0%；归母净利润亏损1.10亿美元，同比亏损缩窄0.1%
华盛资讯8月7日讯，Scholar Rock Holding公布2026财年Q2业绩，公司Q2营收0.00亿美元，同比增长0.0%，归母净利润亏损1.10亿美元，同比亏损缩窄0.1%。
08-07 00:05
Scholar Rock Expands $200 Million At-The-Market Program
Scholar Rock Holding ( ($SRRK) ) has issued an announcement. On August 6, 2026,...
08-06 21:26
Scholar Rock Holding shares are trading higher after the company reported better-than-expected Q2 financial results.
Scholar Rock Holding shares are trading higher after the company reported better-than-expected Q2 financial results.
08-06 20:25
财报速睇 | Scholar Rock Holding 2026财年Q2营收0.00亿美元，同比增长0.0%；归母净利润亏损1.10亿美元，同比亏损缩窄0.1%
华盛资讯8月6日讯，Scholar Rock Holding公布2026财年Q2业绩，公司Q2营收0.00亿美元，同比增长0.0%，归母净利润亏损1.10亿美元，同比亏损缩窄0.1%。
08-06 19:37
Scholar Rock Holding Q2 EPS $(0.84) Beats $(0.85) Estimate; Cash Balance Of $492M
Scholar Rock Holding (NASDAQ:SRRK) reported quarterly losses of $(0.84) per share which beat the analyst consensus estimate of $(0.85) by 1.18 percent. This is a 14.29 percent increase over losses of $(0.98) per share from the same period last year.
08-06 19:04
